Who to call at Cartesian Therapeutics, Inc., and when
Fundz watches for the moments Cartesian Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Cartesian Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cartesian Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cartesian Therapeutics, Inc.. With Fundz connected, it knows.
Cartesian Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
selectabio.comAI Executive Summary
AI-powered analysis of 8-K filing content
Carrie S. Cox resigned from Cartesian Therapeutics' Board effective October 29, 2025, to take an Executive Chair role at another public company, ending her tenure as Chairman since 2019. The Board named Carsten Brunn, Ph.D., as Chairman and Patrick Zenner, M.B.A., as Lead Independent Director, and adopted bylaw changes to reference the new Lead Independent Director role.
Key Takeaways
Carrie S. Cox resigned from the Board effective immediately on October 29, 2025, citing additional responsibilities and time commitments from her new Executive Chair role at another publicly traded co
Cox's resignation was not the result of any disagreement with the Company on its operations, policies, or practices.
3 more takeaways
Related Filings (8)
8 more filings from Cartesian Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Cartesian Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.